Page last updated: 2024-12-07

egta acetoxymethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

EGTA acetoxymethyl ester: membrane-permeable form of EGTA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121907
MeSH IDM0135367

Synonyms (24)

Synonym
6,9-dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(2-((acetyloxy)methoxy)-2-oxoethyl)-, bis((acetyloxy)methyl) ester
egta acetoxymethyl ester
egta/am
99590-86-0
egta-ame
egta-am
acetyloxymethyl 2-[[2-(acetyloxymethoxy)-2-oxoethyl]-[2-[2-[2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]ethoxy]ethoxy]ethyl]amino]acetate
[2-[acetyloxymethoxycarbonylmethyl-[2-[2-[2-(bis(acetyloxymethoxycarbonylmethyl)amino)ethoxy]ethoxy]ethyl]amino]acetyl]oxymethyl acetate
CS-7706
DTXSID00244144
AKOS030530620
HY-D0973
FT-0737483
egta/am - cas 99590-86-0
egta,tetra(acetoxymethyl ester)
bis(acetoxymethyl) 2,11-bis(2-(acetoxymethoxy)-2-oxoethyl)-5,8-dioxa-2,11-diazadodecane-1,12-dicarboxylate
bis(acetoxymethyl) 3,12-bis(2-(acetoxymethoxy)-2-oxoethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioate
ethyleneglycol-bis(beta-aminoethyl)-n,n,n',n'-tetraacetoxymethyl ester
3,12-bis[2-[(acetyloxy)methoxy]-2-oxoethyl]-6,9-dioxa-3,12-diazatetradecanedioic acid 1,14-bis[(acetyloxy)methyl]ester
F85556
MS-31046
ZDA59086
bis(acetoxymethyl)3,12-bis(2-(acetoxymethoxy)-2-oxoethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioate
egta am
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.45)18.7374
1990's16 (23.19)18.2507
2000's37 (53.62)29.6817
2010's13 (18.84)24.3611
2020's2 (2.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]